Odontogenic Tumors
Odontogenic Myxoma
aka Myxofibroma (if fibrous stroma abundant) · Odontogenic Fibromyxoma
Benign but locally infiltrative odontogenic mesenchymal tumour composed of stellate cells in a myxoid stroma; notable for finger-like invasion of medullary bone and 'tennis-racket' radiographic pattern.
Red Flags
- ·Rapid growth, paraesthesia, cortical perforation with soft-tissue mass — reconsider malignancy
Clinical Tips
- ·Always aspirate before biopsying a multilocular radiolucency — a central haemangioma can bleed fatally.
- ·Peripheral ostectomy is essential due to the tumour's infiltrative nature.
Examination Checklist
- ·Bimanual palpation
- ·Nerve function (IAN, mental)
- ·OPG + CBCT ± MRI
- ·Aspiration before open biopsy
§ overviewOverview
A benign, locally infiltrative odontogenic tumour of ectomesenchymal origin, composed of loosely arranged stellate and spindle cells in an abundant myxoid extracellular matrix.
§ icdICD Classification
ICD-10 D16.4/D16.5
§ etiologyEtiology
- 01Origin from odontogenic ectomesenchyme (dental follicle, papilla, periodontal ligament)
§ riskRisk Factors
- 01None specific
§ geneticsGenetics & Molecular Biology
- 01MYB and MDM2 pathway abnormalities reported in some series
- 02Not consistently associated with a specific syndrome
§ epidemiologyEpidemiology
3–20% of odontogenic tumours (regional variation). 2nd–4th decade. F > M. Mandible (66%) > maxilla; posterior region most common.
§ pathogenesisPathogenesis
Neoplastic ectomesenchymal cells produce abundant hyaluronic-acid rich myxoid matrix, which infiltrates between bony trabeculae. Absence of a capsule underlies the finger-like invasion and high recurrence rate.
§ clinicalClinical Features
- 01Slow, painless swelling
- 02Loosening or displacement of teeth
- 03Cortical expansion and thinning
- 04Facial asymmetry
§ signsSigns & Symptoms
- 01Egg-shell crackling
- 02Occasional paraesthesia if IAN involved
- 03Rarely painful
§ differentialDifferential Diagnosis
- 01Ameloblastoma
- 02OKC
- 03Central giant cell granuloma
- 04Aneurysmal bone cyst
- 05Central haemangioma
- 06Fibro-osseous lesion
§ criteriaDiagnostic Criteria
- 01Multilocular radiolucency with straight fine septa (tennis-racket / step-ladder / soap-bubble)
- 02Histology: stellate cells in mucoid stroma with sparse collagen
§ histopathHistopathology
- 01Loose myxoid stroma rich in hyaluronic acid/mucopolysaccharide
- 02Stellate, spindle and round cells with fine cytoplasmic processes
- 03Sparse collagen; occasional odontogenic epithelial rests
- 04No capsule — infiltrative border
§ radiographicRadiographic Features
- 01Multilocular radiolucency with characteristic fine straight bony septa forming 'tennis-racket', 'step-ladder', 'honeycomb' or 'soap-bubble' patterns
- 02Displacement or root resorption of adjacent teeth
- 03Cortical thinning / perforation
§ opgOPG Findings
- 01Screening view; note characteristic septation
§ cbctCBCT Findings
- 01Best imaging for delineation of extent, septation pattern, cortical status
§ ctCT Findings
- 01For extensive lesions with soft-tissue involvement
§ mriMRI Findings
- 01T1 hypointense, T2 markedly hyperintense (myxoid content); heterogeneous enhancement
§ investigationsInvestigations
- 01Incisional biopsy (aspiration first to exclude vascular lesion)
- 02CBCT + MRI for surgical planning
§ labsLaboratory Findings
- 01Aspirate: mucinous stringy fluid, low cellularity
§ ihcIHC / Special Stains
- 01Vimentin positive; S-100 focal; smooth muscle actin variable; MIB-1 (Ki-67) low but higher than dental follicle
§ whoWHO Classification
WHO 2022: Benign odontogenic tumour of mesenchymal origin — Odontogenic myxoma (Odontogenic myxofibroma when fibrous component prominent).
§ classificationClassification
- 01Central (intra-osseous) — vast majority
- 02Peripheral (extraosseous) — extremely rare
§ planTreatment Planning
- 01Balance recurrence risk (25% with curettage) against morbidity of resection
- 02Small (< 3 cm) lesions may permit enucleation with peripheral ostectomy in select cases
- 03Large or recurrent lesions → resection with reconstruction
§ treatmentTreatment
- 01Small lesions: aggressive curettage + peripheral ostectomy ± chemical adjunct (Carnoy's)
- 02Medium/large: marginal or segmental resection with 1–1.5 cm bony margin
- 03Immediate or delayed reconstruction (fibula free flap)
§ medicalMedical Management
- 01Nil disease-specific
§ surgicalSurgical Management
- 01Segmental mandibulectomy with reconstruction plate + free fibula/iliac graft
- 02Marginal resection preserving inferior border where feasible
§ reconstructionReconstruction Options
- 01Reconstruction plate + free fibula osseocutaneous flap for continuity defects
- 02Iliac crest graft for smaller marginal defects
§ complicationsComplications
- 01Recurrence
- 02Cortical perforation with soft-tissue infiltration
- 03Pathologic fracture
- 04Facial deformity
§ recurrenceRecurrence Rate
Curettage: 25%; resection: < 10%. Long-term follow-up mandatory.
§ followupFollow-up Protocol
- 01Clinical + OPG every 6 months for 2 years
- 02Annually for 5 years
- 03Selective CBCT/MRI on suspicion of recurrence
§ prognosisPrognosis
Excellent for lifespan; morbidity from recurrence and reconstruction.
§ preventionPrevention
- 01None
§ examKey Examination Points
- 01Multilocular radiolucency with fine straight septa in a young adult
- 02Aspirate first to rule out vascular lesion
- 03Infiltrative — no capsule — high recurrence with curettage
§ revisionQuick Revision Summary
- 01Ectomesenchymal
- 02Mandible > maxilla
- 03Tennis-racket / step-ladder / soap-bubble
- 04Stellate cells + myxoid stroma
- 05No capsule → recurs; resect with margin
§ vivaBDS Viva Questions
- 01Origin of odontogenic myxoma.
- 02Radiographic patterns.
- 03Why does it recur after curettage?
- 04Histology of myxoma.
- 05Aspiration findings.
- 06Differential of multilocular radiolucency.
- 07Treatment options.
- 08Reconstruction after segmental resection.
- 09Follow-up protocol.
- 10MRI features.
- 11Difference between myxoma and myxofibroma.
- 12Sex and age predilection.
- 13Complications of surgery.
- 14Recurrence rate.
§ bdsBDS Professional Examination
- 01Long essay: Differential diagnosis and management of multilocular radiolucencies of the mandible.
- 02Short note: Odontogenic myxoma.
§ fcpsFCPS Residency Questions
- 01Discuss the surgical management and reconstruction options for a 4 cm odontogenic myxoma of the posterior mandible.
§ pearlsClinical Pearls
- 01Multilocular + straight fine septa + stringy aspirate = myxoma until proven otherwise.
- 02Never curette a multilocular radiolucency without aspirating first.
§ mnemonicsMnemonics
- 01Myxoma = Mucin, Mesenchyme, Mandible, Multilocular, Must resect with Margin
§ readingSuggested Reading
- 01Noffke CEE et al. Odontogenic myxoma: review of the literature and report of 30 cases. Br J Oral Maxillofac Surg 2007.
- 02WHO Blue Book 5e (2022).
§ differentialDifferential Comparison
| Entity | Feature | Distinguisher |
|---|---|---|
| Ameloblastoma | Soap-bubble | Ameloblast-like palisading; BRAF V600E; different histology |
| CGCG | Multilocular anterior mandible | Multinucleated giant cells; often crosses midline |
| Central haemangioma | Multilocular | Aspiration → blood; life-threatening bleed |
§ mcqsMCQs — Assessment (20)
Question 1
Odontogenic myxoma originates from:
Question 2
Classic radiographic pattern:
Question 3
Most common site:
Question 4
Recurrence after curettage:
Question 5
Histology shows:
Question 6
Aspiration typically yields:
Question 7
MRI signal of myxoid stroma:
Question 8
Which is TRUE?
Question 9
Age group most affected:
Question 10
Sex predilection:
Question 11
Which is the BEST treatment for a 4 cm mandibular myxoma?
Question 12
Which is the FIRST step before biopsy of a multilocular radiolucency?
Question 13
IHC most consistently positive:
Question 14
Radiographic differential includes all EXCEPT:
Question 15
Ki-67 index in myxoma is:
Question 16
Myxofibroma differs from myxoma by:
Question 17
Peripheral ostectomy is advised because:
Question 18
Which reconstruction is standard for continuity defect?
Question 19
Recurrence after adequate resection:
Question 20
Which of the following is a warning sign?
References
- WHO Classification of Head and Neck Tumours, 5e (2022)
- Neville BW. Oral and Maxillofacial Pathology, 4e
- Shafer's Textbook of Oral Pathology, 9e
- Peterson LJ. Contemporary Oral & Maxillofacial Surgery, 7e
Draft — pending faculty review. Educational use only; verify against current guidelines and primary sources before clinical application.